SYK unveils new Triathlon knee implants, and expands Mako robotics and power tools, deepening its tech-driven orthopedics ...

Why Stryker is on investors’ radar today Stryker (SYK) has drawn fresh investor attention after recent trading left the shares with a 1 day return of 3% and a 7 day return of 4.0%, against broadly ...

Keith Evans, general manager of Stryker’s Mako and enabling technologies unit, said the handheld robot will be in a limited release for the first half of 2026.

The Synchfix EVT device builds on the previous Synchfix platform and introduces design improvements to minimise procedural ...

Stryker (NYSE: SYK) has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 12.63%. Currently, Stryker has a market capitalization of ...

Stryker has unveiled its latest additively manufactured orthopaedic implant at the American Academy of Orthopaedic Surgeons’ (AAOS) 2026 Annual Meeting. Triathlon Gold builds on the capabilities and ...

Think Surgical today announced the first completed cases using the TMINI miniature robotic system with the Stryker Triathlon knee system.